[144] BitMine Immersion Technologies, Inc. SEC Filing

Rhea-AI Filing Summary

BitMine Immersion Technologies, Inc. (BMNR) filed a Form 144 notifying the proposed sale of 250,000 common shares through UBS Securities LLC on the NYSE, with an aggregate market value listed as $11,895,000.00 and approximately 173,496,950 shares outstanding. The shares were acquired on December 20, 2022 as executive compensation (375,000 shares granted) and paid as executive compensation. The filing reports no other securities sold in the past three months and includes the required representation that the seller is not aware of undisclosed material adverse information.

Positive

• Regulatory compliance: Form 144 filed providing transparent notice of proposed sale
• Clear provenance: Shares were acquired as executive compensation on 12/20/2022, which is disclosed

Negative

• Insider sale proposed: 250,000 common shares to be sold, which may increase share supply
• Aggregate market value listed: $11,895,000.00 planned sale could be perceived negatively by some investors

Insights

Securities Analyst

TL;DR: Routine insider sale notice; provides liquidity detail but no operational disclosures.

The Form 144 is a standard regulatory notice for proposed sale of restricted or control securities. It identifies the broker (UBS Securities LLC), the class (common), the number of shares proposed for sale (250,000), the approximate sale date (09/11/2025), and the origin of the shares (executive compensation granted 12/20/2022). The filing does not disclose changes to the company's operations, results, or financial condition; it solely documents the insider's intention to sell. For investors, the most relevant items are the sale size and timing; the shares represent a small fraction of total outstanding common shares (<0.2%).

Corporate Governance Expert

TL;DR: Governance disclosure completed; raises routine questions about insider liquidity but no governance red flags.

The document fulfils Rule 144 notice requirements and includes the seller's attestation about lack of undisclosed material adverse information. The shares were received as executive compensation, which is material for insider alignment analysis but the filing itself contains no evidence of improper conduct or regulatory issues. Absent accompanying Form 4 or related transaction details, this notice should be treated as a compliance disclosure rather than a signal of governance change.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Securities LLC 11 Madison Avenue New York NY 10010	250000	11895000.00	173496950	09/11/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/20/2022	Executive Cpmpensation	Company			375000	12/20/2022	Exec Comp

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the BMNR Form 144 disclose about the proposed sale?

The filing notifies a proposed sale of 250,000 common shares via UBS Securities LLC on the NYSE with an aggregate market value of $11,895,000.00 and an approximate sale date of 09/11/2025.

How were the shares being sold by BMNR acquired?

The shares were acquired on 12/20/2022 as executive compensation (375,000 shares granted) and payment was recorded as executive compensation.

Does the Form 144 report any securities sold by the insider in the past three months?

No. The filing states "Nothing to Report" for securities sold during the past three months.

Who is the broker named in the BMNR Form 144?

The broker named is UBS Securities LLC, located at 11 Madison Avenue, New York, NY 10010.

What attestation does the seller make in the Form 144?

The seller represents they do not know of any material adverse information about the issuer that has not been publicly disclosed.